Researchers at UC San Francisco have discovered how PGAM1 – a protein expressed at high levels in many cancers – can contribute to tumor cells’ resistance to radiation therapy and chemotherapy.
Hosted by long-time supporters Alan and Ashley Dabbiere, the event also paid tribute to the pioneering work of the Center’s director, Mitchel Berger, MD.
As the Sheri Sobrato Brisson Brain Cancer Survivorship Program entered its second year, it has expanded its offerings for the growing numbers of brain cancer survivors.
Neuro-oncologist Mariza Daras, MD, has joined the faculty at the Brain Tumor Center, in part to play a leading role in coordinating care for patients with CNS metastases.
Semi-annual UCSF Neuro‐Oncology Gordon Murray Caregiver Program Newsletter, Fall 2019
Immunotherapy encompasses a range of strategies aimed at making cancer cells more recognizable and vulnerable to attack by the patient’s immune system.